Since its origin in 1976, Malignant growth Immunology, Immunotherapy (CII) has revealed huge advances in the field of tumor immunology. The diary fills in as a gathering for new ideas and advances in fundamental, translational, and clinical disease immunology and immunotherapy. CII is quick to distribute wide going thoughts and surveys, results which broaden or challenge set up standards, just as negative examinations which neglect to replicate tests that help current ideal models, and papers that do prevail with regards to duplicating others' outcomes in various settings. Cll is particularly intrigued by papers portraying clinical preliminary structures and result whether or not they met their assigned endpoints or not, and especially those revealing insight into immunological components.
CII is subsidiary with the Relationship for Malignancy Immunotherapy (CIMT), Canadian Disease Immunotherapy Consortium (CCIC), The Japanese Relationship for Malignant Growth Immunology (JACI), System Italiano per la Bioterapia dei Tumori (NIBIT), and Sociedad Española de Inmunologia-Grupo Española de Immunotherapies (SEI-GEIT).
Case Report: Cancer Science & Therapy
Case Report: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Scientific Tracks Abstracts: Journal of Bioengineering & Biomedical Science
Cancer Science & Therapy received 5332 citations as per Google Scholar report